Published Date: 21-Apr-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Anti-acne Cosmetics Market, published by KBV research, The Global Anti-acne Cosmetics Market size is expected to reach $3.1 billion by 2026, rising at a market growth of 6.1% CAGR during the forecast period.
The women's end-use segment would exhibit a substantial growth rate during the forecast period. This growth is owing to the high rates of skin disorders among the female population. Acne is extremely pervasive among women as compared to men due to hormonal changes, like during the menstrual cycle. The men end-use segment garnered a considerable revenue share in 2019. The increasing rates of acne in men are further boosting the demand for these products.
The Creams & Lotions market dominated the Global Anti-acne Cosmetics Market by Product in 2019. The other segment would display a prominent growth rate during the forecast period. This segment involves items like gels, face wash, serums, and essential oils. The growth of the segment is boosted by the massive demand for these items because of their compatibility with different skin types.
The Asia Pacific market dominated the Global Anti-acne Cosmetics Market by Region in 2019, growing at a CAGR of 6.8 % during the forecast period. The North America market is experiencing a CAGR of 4.8% during (2020 - 2026). Additionally, The Europe market is estimated to grow at a CAGR of 5.7% during (2020 - 2026).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Estee Lauder Companies, Inc. (Clinique), Unilever PLC (Murad Skincare), Johnson and Johnson, L'Oreal Group, LVMH SE, Beiersdorf AG, KOSE Corporation, Rohto Pharmaceutical Co., Ltd. (Mentholatum), The Proactiv Company LLC (Guthy-Renker LLC), and Ancalima Lifesciences Limited.
By End Use
Unique Offerings from KBV Research